RABINOWITZ DANIEL sold $485K of NTRA
RABINOWITZ DANIEL (SEC. AND CHIEF LEGAL OFFICER) sold 1,887 shares of Natera, Inc. (NTRA) at an average of $257.08 ($254.07–$260.49, $0.49M total) across 2 trades over 2026-07-27 to 2026-07-28 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the record of insider activity but does not change Natera’s business outlook based on the information provided.
Market read
Insider selling under a 10b5-1 plan is generally low-signal; any trading impact is likely limited unless corroborated by other negative catalysts.
What to watch
Traders should check whether there were concurrent insider buys/sales by other executives and whether the sale size is unusual relative to prior Form 4 activity.
Background
The article is a primary-source SEC Form 4 insider transaction for Natera, Inc.
Ticker impact
Natera Form 4 shows Daniel Rabinowitz, Chief Legal Officer, sold 1,887 shares in open-market trades under a 10b5-1 plan at $254.07 to $260.49.
Likely limited, short-lived impact unless paired with other negative company news.
The filing is a routine 10b5-1 open-market sale by an officer; it does not provide new operational, financial, or regulatory information.
Market effects
Minimal; insider sale in a single biotech/health-tech name does not reset sector fundamentals.
Minimal; US-listed filing with no broader macro/regional catalyst.
Minimal; no international transaction or regulatory action described.
Counterpoint
Because the trades are explicitly under a pre-arranged 10b5-1 plan, the sale may reflect diversification or liquidity needs rather than a bearish view.
Key entities
- issuerNatera, Inc.
US-listed company whose officer insider sale is disclosed via SEC Form 4.
- insiderDaniel Rabinowitz
Chief Legal Officer who sold shares in open-market transactions under a 10b5-1 plan.
